Commercial Operations

Are Life Sciences Industry Sales Compensation Strategies Misaligned Globally?


The COVID-19 pandemic has caused severe disruptions and surfaced numerous vulnerabilities in life sciences and pharma company sales organizations and functions, historically a primary driver of product revenues and healthcare provider engagement.

As the life sciences industry begins to transition back to a mixed digital/direct sales and HCP engagement strategy, now is an opportune time for companies to rethink and reassess their current global sales compensation programs to make sure their local field forces around the world are optimally aligned with those programs and identify and correct any areas of misalignment.

Axtria (Axtria SalesIQ: Pharma Sales Cloud, Sales Operations, Sales Management) led a session on this topic entitled “Building a Global Sales Compensation Function to Enable Local Strategy” at the Sales Comp WorldatWork Conference, just concluded in Chicago https://www.worldatwork.org/events/2021-spotlight-on-sales-compensation.

“A global sales compensation function needs to balance corporate standards and best practices with different local market needs,” said Vineet Rathi, Principal, Axtria, and co-presenter of the session. “Too much independent control can create misalignment with global strategy, while centralized control can miss known differential market needs and practices. In our session, we shared with conference attendees a framework for structuring a global sales compensation function.”

The session also examined how and which sales compensation decisions and processes should be more globally or locally driven, how to structure global and local sales compensation committees, sales compensation decision-making at the global and local level, and sales compensation scorecards.

“We were delighted to have Axtria present on such a timely topic that gave companies an opportunity to take a top to bottom down look at where their sales compensation strategies are now across their organizations and offices across the globe,” added Muriel Neddemeyer, Marketing Manager, WorldatWork. “Their work in the sales comp and incentive program consulting and sales data analytics and AI technology space is extensive, and our attendees benefited from their expertise and knowledge-sharing in these areas.”

Axtria’s session was presented by Vineet Rathi, Principal, Commercial Excellence; Daniel Stewart, Director of Commercial Excellence; Abhijit Paul, Director of Sales Operations and Strategy; and Ellie Houck, Senior Associate.

About Axtria's Products and Solutions

Axtria is the market leader in agentic-AI powered products and services for the life sciences industry. Our cloud solutions and domain-trained agents help organizations accelerate commercialization, enhance decision-making, and deliver measurable business impact across the value chain. We deliver value through an integrated approach that combines deep domain expertise and strategic consulting with our AI-native cloud software suite. Our Agentic AI portfolio empowers life sciences organizations to accelerate innovation and make smarter, faster decisions. Axtria InsightsMAx.ai serves as the enterprise-grade platform that unites intelligence, automation, and orchestration across the commercialization journey. Axtria SalesIQ™ drives field force and provider effectiveness with embedded AI insights, Axtria CustomerIQ™ orchestrates personalized experiences through next-best-action intelligence, Axtria MarketingIQ™transforms commercial investments into precision strategies, and Axtria DataMAx™ provides the secure, trusted data foundation that powers every AI and Agentic AI transformation.

Contact Information

Anjali Kumari
Axtria, Inc.
anjali.kumari1@axtria.com

About Axtria

Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We’re proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.